HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Duchenne muscular dystrophy: prolongation of life by noninvasive ventilation and mechanically assisted coughing.

AbstractOBJECTIVE:
To quantitate prolongation of survival for patients with Duchenne muscular dystrophy with the use of noninvasive intermittent positive-pressure ventilation (IPPV) with and without access to a protocol involving mechanically assisted coughing.
DESIGN:
In this retrospective review of all patients with Duchenne muscular dystrophy visiting a neuromuscular disease clinic, patients were trained to use mouth piece and nasal IPPV and mechanically assisted coughing to maintain oxyhemoglobin saturation >94% (protocol). Survival was considered prolonged when noninvasive IPPV was required full time.
RESULTS:
Ninety-one of 125 patients used noninvasive IPPV part time for 1.9 +/- 1.3 yr, and 51 went on to require it full time for 6.3 +/- 4.6 yr. Of the 31 noninvasive IPPV users who died without access to the protocol, 20 died from respiratory causes and seven died from cardiac causes. None of the 34 full-time noninvasive IPPV users with access to the protocol underwent tracheotomy or died from respiratory complications during a period of 5.4 +/- 4.0 yr, whereas three died from heart failure. Five patients with no breathing tolerance were extubated or decannulated to continuous noninvasive IPPV.
CONCLUSIONS:
Noninvasive respiratory aids can prolong survival and permit extubation or decannulation of patients with Duchenne muscular dystrophy with no breathing tolerance.
AuthorsElia Gomez-Merino, John R Bach
JournalAmerican journal of physical medicine & rehabilitation (Am J Phys Med Rehabil) Vol. 81 Issue 6 Pg. 411-5 (Jun 2002) ISSN: 0894-9115 [Print] United States
PMID12023596 (Publication Type: Journal Article)
Topics
  • Adolescent
  • Adult
  • Cause of Death
  • Cough (etiology)
  • Humans
  • Intermittent Positive-Pressure Ventilation
  • Muscular Dystrophies (mortality, therapy)
  • Retrospective Studies
  • Survival Analysis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: